Journal of neuroimaging : official journal of the American Society of Neuroimaging
-
Multicenter Study Clinical Trial Controlled Clinical Trial
Transcranial duplex imaging with a sulfurhexafluoride echocontrast agent: enhancement and diagnostic quality.
The authors investigate characteristics of ultrasound enhancement and diagnostic quality of a sulfurhexafluorides (SF6)-containing echocontrast agent (SonoVue) in cerebrovascular patients with insufficient temporal bone window by transcranial color-coded duplex (TCCD) sonography. ⋯ Administration of SonoVue led to a quality improvement in 21 patients. In TCCD, it optimizes visualization of the cerebral arteries in patients with inadequate bone window. A dose of at least 1.2 mL provides the best enhanced images.